NCT04925544
- Conditions
- Carcinoma, DNA Virus Infections, Epstein-Barr Virus Infections, +19 more
- Locations
-
- Stanford University Stanford, California, United States
Clinical trial condition
Otorhinolaryngologic Neoplasms
Explore clinical trials studying Otorhinolaryngologic Neoplasms. Study availability and eligibility vary by location and protocol.
912 public trials
267 recruiting studies
Otorhinolaryngologic Neoplasms trial results
Active, Not Recruiting
Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma
NCT03097939
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
- Locations
-
- National Cancer Center Singapore Singapore
Active, Not Recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
- Conditions
- Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
Active, Not Recruiting
Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin
NCT04533750
- Conditions
- Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous Cell Carcinoma, +34 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
Active, Not Recruiting
Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis
NCT07420751
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +31 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Active, Not Recruiting
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
NCT04708470
- Conditions
- Anal Cancer, Anus Diseases, Anus Neoplasms, +49 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Active, Not Recruiting
Radiotherapy Dose De-escalation in HPV-Associated Cancers of the Oropharynx
NCT04667585
- Conditions
- Head and Neck Neoplasms, Neoplasms, Neoplasms by Site, +7 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
- Duke Raleigh Hospital Raleigh, North Carolina, United States
Active, Not Recruiting
Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer
NCT03224000
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +13 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma
NCT05784012
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +17 more
- Locations
-
- Institut Catalá d'Oncologia (ICO) BADALONA Badalona, Catalonia, Spain
- Hospital Universitario Valle Hebron Barcelona, Catalonia, Spain
- Hospital Clinic de Barcelona Barcelona, Catalonia, Spain
- Institut Catalá d'Oncologia (ICO) Hospitalet L'Hospitalet de Llobregat, Catalonia, Spain
Active, Not Recruiting
Pembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal Cancer
NCT04825990
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
- Locations
-
- Asst Degli Spedali Civili Di Brescia Brescia, Italy